Teva buys 51% stake in Genomic-Analysis Company Immuneering for $60 million

Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA; TASE: TEVA) has announced the acquisition of 51% of Immuneering Corporation, a privately-held genomic-analysis company based in Cambrige, Massachusetts. More...